Update on side effects from common vaccines

Current Allergy and Asthma Reports

Volumn 4, Issue 6, 2004, Pages 447-453

  Song, Benjamin J ^a   Katial, Rohit K ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TETANUS TOXOID; VIRUS VACCINE;

ANAPHYLACTOID PURPURA; ANAPHYLAXIS; ANOREXIA; ARTHRITIS; ASEPTIC MENINGITIS; AUTISM; BACTERIAL INFECTION; BELL PALSY; BRAIN DISEASE; CHICKENPOX; COMPLEX REGIONAL PAIN SYNDROME; CONJUNCTIVITIS; CYANOSIS; DIPHTHERIA; DISEASE ASSOCIATION; DROWSINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; ERYTHEMA; EYE PAIN; FACE EDEMA; FEBRILE CONVULSION; FEVER; GUILLAIN BARRE SYNDROME; HEPATITIS B; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLUENZA; INJECTION PAIN; INTUSSUSCEPTION; IRRITABILITY; MEASLES; MUMPS; MUSCLE HYPOTONIA; MYELITIS; OCULORESPIRATORY SYNDROME; OPTIC NERVE DISEASE; OTITIS MEDIA; PARALYSIS; PERTUSSIS; PHOTOPHOBIA; POLIOMYELITIS; RESPIRATORY TRACT DISEASE; REVIEW; RUBELLA; SIDE EFFECT; SKIN EDEMA; SKIN MANIFESTATION; TETANUS; THROMBOCYTOPENIA; VASCULITIS; VASODILATATION; VIRUS INFECTION; VISUAL IMPAIRMENT;

EID: 9744274003     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0010-8     Document Type: Review

References (42)

1. Ales NC, Katial RK: Vaccines against biologic agents: uses and development. Respir Care Clin North Am 2004, 10: 23-146.
2. Jacobson RM: Vaccine safety. Immunol Allergy Clin North Am 2003, 23:589-603.
3. Zhou W, Pool V, Iskander JK, et al.: Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Morbid Mortal Wkly Rep 2003, 52:1-24.
4. Tata LJ, West J, Farrington P, et al.: Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003, 58:835-839.
5. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al.: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology 1979, 110:105-123.
6. Geier MR, Geier DA, Zahalsky AC: Influenza vaccination and Guillain Barre Syndrome. Clin Immunol 2003, 107:116-121.
7. DeKeyser J, Zwanikken C, Boon M: Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 1998, 159:51-53.
8. Mutsch M, Zhou W, Rhodes P, et al.: Use of inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350:896-903.
9. De Serres G, Boulianne N, Duval B, et al.: Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine. Vaccine 2003, 21:2346-2353.
10. De Serres G, Grenier JL, Toth E, et al.: The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination. Vaccine 2003, 21:2354-2361.
11. Jastaniah WA, Dobson S, Lugsdin JG, Petty RE: Complex regional pain syndrome after hepatitis B vaccine. J Pediatr 2003, 143:802-804.
12. Duclos P: Safety of immunization and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf 2003, 2:225-231.
13. Black C, Kaye JA, Jick H: MMR vaccine and idiopathic thrombo-cytopaenic purpura. Br J Clin Pharmacol 2003, 55: 07-111.
14. Jadavji T, Scheiflele D, Halperin S: Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J 2003, 22:119-122.
15. Ki M, Park T, Yi SG, et al.: Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design. Am J Epidemiol 2003, 157:158-165.
16. LeSaux N, Barrowman NJ, Moore DL, et al.: Decrease in hospital admissions for febrile seizures and reports of hypotonic-hypo-responsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 2003, 112:e348-353.
17. Wakefield AJ, Murch SH, Anthony A, et al.: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351: 37-641.
18. Kaye JA: Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001, 322:460-463.
19. Dales L, Hammer SJ, Smith NJ: Time trends in autism and in MMR immunization coverage in California. J Am Med Assoc 2001, 285:1183-1185.
20. Madsen KM, Hviid A, Vertergaard M, et al.: MMR vaccination and autism - a population-based follow-up study. Ugeskr Laeger 2003, 164:5741-5744.
21. Taylor B, Miller E, Farrington CP, et al.: Autism and measles, mumps, and rubella vaccine: no epidemiologic evidence for a causal association. Lancet 1999; 353:2026-2029.
22. Taylor B, Miller E, Lingam R, et al.: Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002, 324:393-396.
23. Wilson K, Mills E, Ross C, et al.: Association of autistic spectrum disorder and the measles, mumps and rubella vaccine. Arch Pediatr Adolesc Med 2003, 157:628-634.
24. Fombonne E, Chakrabarti S: No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001, 108:e58-64.
25. Andrews N, Miller E, Taylor B, et al.: Recall bias, MMR and autism. Arch Dis Child 2002, 87:493-494.
26. The National Academies: Immunization Safety Review: vaccines and autism. http://www4.nationalacademies.org/news.nsf/isbn/ s030909237X? OpenDocument. Accessed June 1, 2004.
27. Halperin SA, Scheifele D, Mills E, et al.: Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine 2003, 21: 298-2306.
28. Woo EJ, Burwen DR, Gatumu SNM, Ball R: Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system. Clin Infect Dis 2003, 37:351-358.
29. Cody CL, Baraff LJ, Cherry JD, et al.: Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981, 68:650-659.
30. DuVernoy TS, Braun MM: Hypotonic-hyporesponsive episodes reported to the vaccine adverse event reporting system (VAERS), 1996-1998. Pediatrics 2000, 106:e52-e61.
31. Mayorga C, Torres MJ, Corzo JL, et al.: Immediate allergy to tetanus vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol 2003, 90:238-243.
32. Engels EA, Katki HA, Nielsen NM, et al.: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003, 95:532-539.
33. Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J: Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Ann N Y Acad Sci 2003, 1005:404-408.
34. Murphy TV, Smith PJ, Gargiullo PM, Schwartz B: The first rota-virus vaccine and intussusception epidemiological studies and policy decisions. J Infect Dis 2003, 187:1309-1313.
35. Gershon A: Varicella vaccine: rare serious problems - but the benefits still outweigh the risks. J Infect Dis 2003, 188:945-947.
36. Offit PA, Jew RK: Addressing parents' concerns: Do vaccines contain harmful preservatives, adjuvants, additives or residuals? Pediatrics 2003, 112:1394-1401.
37. Geier MR, Geier DA: Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exper Biol Med 2003, 228:660-664.
38. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M: Association between thimerosal-containing vaccine and autism. JAMA 2003, 290:1763-1766.
39. Stehr-Green P, Tull P, Stellfeld M, et al.: Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prevent Med 2003, 25:101-106.
40. Grabestein J, Pharm MS: Clinical management of hyper-sensitivities to vaccine components. Hosp Pharm 1997, 32:77-78.
41. Jefferson T, Rudin M, DiPietrantonj C: Adverse events after immunization with aluminum-containing DTP vaccines: systematic review of evidence. Lancet Infect Dis 2004, 4:84-90.
42. Zeiger RS: Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002, 110:834-840.